Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albiglutide Dose Finding in Japanese T2DM
NCT01098461Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2010
- Primary completion
- May 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of albiglutide in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Apr 2010; status: completed.
02
Drugs
albiglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01098461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01098461.